Stada Partners With Calliditas On Novel Budesonide Formulation

Deal Worth Over $100m Targets First European Approval For Orphan IgAN Treatment

Jul 21 2021

Stada has partnered with Calliditas on its innovative budesonide formulation • Source: Alamy